MASH TREATMENT UPDATE

Altimmune stock took a huge hit after its liver disease drug, pemvidutide, failed to show strong results in reducing fibrosis during a key ...

The achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record for prescriptio...

A new international study has found that over 15 million people across the US, UK, Germany, and France are unknowingly living with metaboli...